Newborn (infant) (liveborn) (singleton)

"Newborn (infant) (liveborn) (singleton)" References in the ICD-10-CM Index to Diseases and Injuries

References in the ICD-10-CM Index to Diseases and Injuries applicable to the clinical term "newborn (infant) (liveborn) (singleton)"

  • Newborn (infant) (liveborn) (singleton) - Z38.2 Single liveborn infant, unspecified as to place of birth
    • abstinence syndrome - P96.1 Neonatal withdrawal symptoms from maternal use of drugs of addiction
    • acne - L70.4 Infantile acne
    • affected by
      • abnormalities of membranes - P02.9 Newborn affected by abnormality of membranes, unspecified
        • specified NEC - P02.8 Newborn affected by other abnormalities of membranes
      • abruptio placenta - P02.1 Newborn affected by other forms of placental separation and hemorrhage
      • amino-acid metabolic disorder, transitory - P74.8 Other transitory metabolic disturbances of newborn
      • amniocentesis (while in utero) - P00.6 Newborn affected by surgical procedure on mother
      • amnionitis - P02.78 Newborn affected by other conditions from chorioamnionitis
      • apparent life threatening event (ALTE) - R68.13 Apparent life threatening event in infant (ALTE)
      • bleeding (into)
        • cerebral cortex - P52.22 Intraventricular (nontraumatic) hemorrhage, grade 4, of newborn
        • germinal matrix - P52.0 Intraventricular (nontraumatic) hemorrhage, grade 1, of newborn
        • ventricles - P52.1 Intraventricular (nontraumatic) hemorrhage, grade 2, of newborn
      • breech delivery - P03.0 Newborn affected by breech delivery and extraction
      • cardiac arrest - P29.81 Cardiac arrest of newborn
      • cardiomyopathy - I42.8 Other cardiomyopathies
        • congenital - I42.4 Endocardial fibroelastosis
      • cerebral ischemia - P91.0 Neonatal cerebral ischemia
      • Cesarean delivery - P03.4 Newborn affected by Cesarean delivery
      • chemotherapy agents - P04.11 Newborn affected by maternal antineoplastic chemotherapy
      • chorioamnionitis - P02.78 Newborn affected by other conditions from chorioamnionitis
      • cocaine (crack) - P04.41 Newborn affected by maternal use of cocaine
      • complications of labor and delivery - P03.9 Newborn affected by complication of labor and delivery, unspecified
        • specified NEC - P03.89 Newborn affected by other specified complications of labor and delivery
      • compression of umbilical cord NEC - P02.5 Newborn affected by other compression of umbilical cord
      • contracted pelvis - P03.1 Newborn affected by other malpresentation, malposition and disproportion during labor and delivery
      • cyanosis - P28.2 Cyanotic attacks of newborn
      • delivery - P03.9 Newborn affected by complication of labor and delivery, unspecified
        • Cesarean - P03.4 Newborn affected by Cesarean delivery
        • forceps - P03.2 Newborn affected by forceps delivery
        • vacuum extractor - P03.3 Newborn affected by delivery by vacuum extractor [ventouse]
      • drugs of addiction - P04.40 Newborn affected by maternal use of unspecified drugs of addiction
        • cocaine - P04.41 Newborn affected by maternal use of cocaine
        • hallucinogens - P04.42 Newborn affected by maternal use of hallucinogens
        • specified drug NEC - P04.49 Newborn affected by maternal use of other drugs of addiction
      • entanglement (knot) in umbilical cord - P02.5 Newborn affected by other compression of umbilical cord
      • environmental chemicals - P04.6 Newborn affected by maternal exposure to environmental chemical substances
      • fetal (intrauterine)
        • growth retardation - P05.9 Newborn affected by slow intrauterine growth, unspecified
        • inflammatory response syndrome (FIRS) - P02.70 Newborn affected by fetal inflammatory response syndrome
        • malnutrition not light or small for gestational age - P05.2 Newborn affected by fetal (intrauterine) malnutrition not light or small for gestational age
      • FIRS (fetal inflammatory response syndrome) - P02.70 Newborn affected by fetal inflammatory response syndrome
      • forceps delivery - P03.2 Newborn affected by forceps delivery
      • heart rate abnormalities
        • bradycardia - P29.12 Neonatal bradycardia
        • intrauterine - P03.819 Newborn affected by abnormality in fetal (intrauterine) heart rate or rhythm, unspecified as to time of onset
          • before onset of labor - P03.810 Newborn affected by abnormality in fetal (intrauterine) heart rate or rhythm before the onset of labor
          • during labor - P03.811 Newborn affected by abnormality in fetal (intrauterine) heart rate or rhythm during labor
        • tachycardia - P29.11 Neonatal tachycardia
      • hemorrhage (antepartum) - P02.1 Newborn affected by other forms of placental separation and hemorrhage
        • cerebellar (nontraumatic) - P52.6 Cerebellar (nontraumatic) and posterior fossa hemorrhage of newborn
        • intracerebral (nontraumatic) - P52.4 Intracerebral (nontraumatic) hemorrhage of newborn
        • intracranial (nontraumatic) - P52.9 Intracranial (nontraumatic) hemorrhage of newborn, unspecified
          • specified NEC - P52.8 Other intracranial (nontraumatic) hemorrhages of newborn
        • intraventricular (nontraumatic) - P52.3 Unspecified intraventricular (nontraumatic) hemorrhage of newborn
          • grade 1 - P52.0 Intraventricular (nontraumatic) hemorrhage, grade 1, of newborn
          • grade 2 - P52.1 Intraventricular (nontraumatic) hemorrhage, grade 2, of newborn
          • grade 3 - P52.21 Intraventricular (nontraumatic) hemorrhage, grade 3, of newborn
          • grade 4 - P52.22 Intraventricular (nontraumatic) hemorrhage, grade 4, of newborn
        • posterior fossa (nontraumatic) - P52.6 Cerebellar (nontraumatic) and posterior fossa hemorrhage of newborn
        • subarachnoid (nontraumatic) - P52.5 Subarachnoid (nontraumatic) hemorrhage of newborn
        • subependymal - P52.0 Intraventricular (nontraumatic) hemorrhage, grade 1, of newborn
          • with intracerebral extension - P52.22 Intraventricular (nontraumatic) hemorrhage, grade 4, of newborn
          • with intraventricular extension - P52.1 Intraventricular (nontraumatic) hemorrhage, grade 2, of newborn
            • with enlargment of ventricles - P52.21 Intraventricular (nontraumatic) hemorrhage, grade 3, of newborn
          • without intraventricular extension - P52.0 Intraventricular (nontraumatic) hemorrhage, grade 1, of newborn
      • hypoxic ischemic encephalopathy [HIE] - P91.60 Hypoxic ischemic encephalopathy [HIE], unspecified
        • mild - P91.61 Mild hypoxic ischemic encephalopathy [HIE]
        • moderate - P91.62 Moderate hypoxic ischemic encephalopathy [HIE]
        • severe - P91.63 Severe hypoxic ischemic encephalopathy [HIE]
      • induction of labor - P03.89 Newborn affected by other specified complications of labor and delivery
      • intestinal perforation - P78.0 Perinatal intestinal perforation
      • intrauterine (fetal) blood loss - P50.9 Newborn affected by intrauterine (fetal) blood loss, unspecified
        • due to (from)
          • cut end of co-twin cord - P50.5 Newborn affected by intrauterine (fetal) blood loss from cut end of co-twin's cord
          • hemorrhage into
            • co-twin - P50.3 Newborn affected by hemorrhage into co-twin
            • maternal circulation - P50.4 Newborn affected by hemorrhage into maternal circulation
          • placenta - P50.2 Newborn affected by intrauterine (fetal) blood loss from placenta
          • ruptured cord blood - P50.1 Newborn affected by intrauterine (fetal) blood loss from ruptured cord
          • vasa previa - P50.0 Newborn affected by intrauterine (fetal) blood loss from vasa previa
        • specified NEC - P50.8 Newborn affected by other intrauterine (fetal) blood loss
      • intrauterine (fetal) hemorrhage - P50.9 Newborn affected by intrauterine (fetal) blood loss, unspecified
      • intrauterine (in utero) procedure - P96.5 Complication to newborn due to (fetal) intrauterine procedure
      • malpresentation (malposition) NEC - P03.1 Newborn affected by other malpresentation, malposition and disproportion during labor and delivery
      • maternal (complication of) (use of)
        • alcohol - P04.3 Newborn affected by maternal use of alcohol
        • amphetamines - P04.16 Newborn affected by maternal use of amphetamines
        • analgesia (maternal) - P04.0 Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
        • anesthesia (maternal) - P04.0 Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
        • anticonvulsants - P04.13 Newborn affected by maternal use of anticonvulsants
        • antidepressants - P04.15 Newborn affected by maternal use of antidepressants
        • antineoplastic chemotherapy - P04.11 Newborn affected by maternal antineoplastic chemotherapy
        • anxiolytics - P04.1A Newborn affected by maternal use of anxiolytics
        • blood loss - P02.1 Newborn affected by other forms of placental separation and hemorrhage
        • cannabis - P04.81 Newborn affected by maternal use of cannabis
        • circulatory disease - P00.3 Newborn affected by other maternal circulatory and respiratory diseases
        • condition - P00.9 Newborn affected by unspecified maternal condition
          • specified NEC - P00.89 Newborn affected by other maternal conditions
        • cytotoxic drugs - P04.12 Newborn affected by maternal cytotoxic drugs
        • delivery - P03.9 Newborn affected by complication of labor and delivery, unspecified
          • Cesarean - P03.4 Newborn affected by Cesarean delivery
          • forceps - P03.2 Newborn affected by forceps delivery
          • vacuum extractor - P03.3 Newborn affected by delivery by vacuum extractor [ventouse]
        • diabetes mellitus (pre-existing) - P70.1 Syndrome of infant of a diabetic mother
        • disorder - P00.9 Newborn affected by unspecified maternal condition
          • specified NEC - P00.89 Newborn affected by other maternal conditions
        • drugs (addictive) (illegal) NEC - P04.49 Newborn affected by maternal use of other drugs of addiction
        • ectopic pregnancy - P01.4 Newborn affected by ectopic pregnancy
        • gestational diabetes - P70.0 Syndrome of infant of mother with gestational diabetes
        • group B streptococcus (GBS) colonization (positive) - P00.82 Newborn affected by (positive) maternal group B streptococcus (GBS) colonization
        • hemorrhage - P02.1 Newborn affected by other forms of placental separation and hemorrhage
        • hypertensive disorder - P00.0 Newborn affected by maternal hypertensive disorders
        • incompetent cervix - P01.0 Newborn affected by incompetent cervix
        • infectious disease - P00.2 Newborn affected by maternal infectious and parasitic diseases
        • injury - P00.5 Newborn affected by maternal injury
        • labor and delivery - P03.9 Newborn affected by complication of labor and delivery, unspecified
        • malpresentation before labor - P01.7 Newborn affected by malpresentation before labor
        • maternal death - P01.6 Newborn affected by maternal death
        • medical procedure - P00.7 Newborn affected by other medical procedures on mother, not elsewhere classified
        • medication - P04.19 Newborn affected by maternal use of unspecified medication
          • specified type NEC - P04.18 Newborn affected by other maternal medication
        • multiple pregnancy - P01.5 Newborn affected by multiple pregnancy
        • nutritional disorder - P00.4 Newborn affected by maternal nutritional disorders
        • oligohydramnios - P01.2 Newborn affected by oligohydramnios
        • opiates - P04.14 Newborn affected by maternal use of opiates
          • administered for procedures during pregnancy or labor and delivery - P04.0 Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
        • parasitic disease - P00.2 Newborn affected by maternal infectious and parasitic diseases
        • periodontal disease - P00.81 Newborn affected by periodontal disease in mother
        • placenta previa - P02.0 Newborn affected by placenta previa
        • polyhydramnios - P01.3 Newborn affected by polyhydramnios
        • precipitate delivery - P03.5 Newborn affected by precipitate delivery
        • pregnancy - P01.9 Newborn affected by maternal complication of pregnancy, unspecified
          • specified - P01.8 Newborn affected by other maternal complications of pregnancy
        • premature rupture of membranes - P01.1 Newborn affected by premature rupture of membranes
        • renal disease - P00.1 Newborn affected by maternal renal and urinary tract diseases
        • respiratory disease - P00.3 Newborn affected by other maternal circulatory and respiratory diseases
        • sedative-hypnotics - P04.17 Newborn affected by maternal use of sedative-hypnotics
        • surgical procedure - P00.6 Newborn affected by surgical procedure on mother
        • tranquilizers administered for procedures during pregnancy or labor and delivery - P04.0 Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
        • urinary tract disease - P00.1 Newborn affected by maternal renal and urinary tract diseases
        • uterine contraction (abnormal) - P03.6 Newborn affected by abnormal uterine contractions
      • meconium peritonitis - P78.0 Perinatal intestinal perforation
      • membrane abnormalities - P02.9 Newborn affected by abnormality of membranes, unspecified
        • specified NEC - P02.8 Newborn affected by other abnormalities of membranes
      • membranitis - P02.78 Newborn affected by other conditions from chorioamnionitis
      • methamphetamine (s) - P04.49 Newborn affected by maternal use of other drugs of addiction
      • mixed metabolic and respiratory acidosis - P84 Other problems with newborn
      • neonatal abstinence syndrome - P96.1 Neonatal withdrawal symptoms from maternal use of drugs of addiction
      • noxious substances transmitted via placenta or breast milk - P04.9 Newborn affected by maternal noxious substance, unspecified
        • cannabis - P04.81 Newborn affected by maternal use of cannabis
        • specified NEC - P04.89 Newborn affected by other maternal noxious substances
      • nutritional supplements - P04.5 Newborn affected by maternal use of nutritional chemical substances
      • placenta previa - P02.0 Newborn affected by placenta previa
      • placental
        • abnormality (functional) (morphological) - P02.20 Newborn affected by unspecified morphological and functional abnormalities of placenta
          • specified NEC - P02.29 Newborn affected by other morphological and functional abnormalities of placenta
        • dysfunction - P02.29 Newborn affected by other morphological and functional abnormalities of placenta
        • infarction - P02.29 Newborn affected by other morphological and functional abnormalities of placenta
        • insufficiency - P02.29 Newborn affected by other morphological and functional abnormalities of placenta
        • separation NEC - P02.1 Newborn affected by other forms of placental separation and hemorrhage
        • transfusion syndromes - P02.3 Newborn affected by placental transfusion syndromes
      • placentitis - P02.78 Newborn affected by other conditions from chorioamnionitis
      • precipitate delivery - P03.5 Newborn affected by precipitate delivery
      • prolapsed cord - P02.4 Newborn affected by prolapsed cord
      • respiratory arrest - P28.81 Respiratory arrest of newborn
      • slow intrauterine growth - P05.9 Newborn affected by slow intrauterine growth, unspecified
      • tobacco - P04.2 Newborn affected by maternal use of tobacco
      • twin to twin transplacental transfusion - P02.3 Newborn affected by placental transfusion syndromes
      • umbilical cord (tightly) around neck - P02.5 Newborn affected by other compression of umbilical cord
      • umbilical cord condition - P02.60 Newborn affected by unspecified conditions of umbilical cord
        • short cord - P02.69 Newborn affected by other conditions of umbilical cord
        • specified NEC - P02.69 Newborn affected by other conditions of umbilical cord
      • uterine contractions (abnormal) - P03.6 Newborn affected by abnormal uterine contractions
      • vasa previa - P02.69 Newborn affected by other conditions of umbilical cord
        • from intrauterine blood loss - P50.0 Newborn affected by intrauterine (fetal) blood loss from vasa previa
    • apnea - See Also: Apnea, newborn; - P28.40 Unspecified apnea of newborn
      • obstructive - P28.42 Obstructive apnea of newborn
      • primary - See Also: Apnea, newborn, sleep, primary; - P28.30 Primary sleep apnea of newborn, unspecified
      • sleep (central) (obstructive) (primary) - See Also: Apnea, newborn, sleep, primary; - P28.30 Primary sleep apnea of newborn, unspecified
    • born in hospital - Z38.00 Single liveborn infant, delivered vaginally
      • by cesarean - Z38.01 Single liveborn infant, delivered by cesarean
    • born outside hospital - Z38.1 Single liveborn infant, born outside hospital
    • breast buds - P96.89 Other specified conditions originating in the perinatal period
    • breast engorgement - P83.4 Breast engorgement of newborn
    • check-up - See: Newborn, examination;
    • convulsion - P90 Convulsions of newborn
    • dehydration - P74.1 Dehydration of newborn
    • examination
      • 8 to 28 days old - Z00.111 Health examination for newborn 8 to 28 days old
      • under 8 days old - Z00.110 Health examination for newborn under 8 days old
    • fever - P81.9 Disturbance of temperature regulation of newborn, unspecified
      • environmentally-induced - P81.0 Environmental hyperthermia of newborn
    • hyperbilirubinemia - P59.9 Neonatal jaundice, unspecified
      • of prematurity - P59.0 Neonatal jaundice associated with preterm delivery
    • hypernatremia - P74.21 Hypernatremia of newborn
    • hyponatremia - P74.22 Hyponatremia of newborn
    • infection - P39.9 Infection specific to the perinatal period, unspecified
      • candidal - P37.5 Neonatal candidiasis
      • specified NEC - P39.8 Other specified infections specific to the perinatal period
      • urinary tract - P39.3 Neonatal urinary tract infection
    • jaundice - P59.9 Neonatal jaundice, unspecified
      • due to
        • breast milk inhibitor - P59.3 Neonatal jaundice from breast milk inhibitor
        • hepatocellular damage - P59.20 Neonatal jaundice from unspecified hepatocellular damage
          • specified NEC - P59.29 Neonatal jaundice from other hepatocellular damage
        • preterm delivery - P59.0 Neonatal jaundice associated with preterm delivery
      • of prematurity - P59.0 Neonatal jaundice associated with preterm delivery
      • specified NEC - P59.8 Neonatal jaundice from other specified causes
    • late metabolic acidosis - P74.0 Late metabolic acidosis of newborn
    • mastitis - P39.0 Neonatal infective mastitis
      • infective - P39.0 Neonatal infective mastitis
      • noninfective - P83.4 Breast engorgement of newborn
    • multiple born NEC - Z38.8 Other multiple liveborn infant, unspecified as to place of birth
      • born in hospital - Z38.68 Other multiple liveborn infant, delivered vaginally
        • by cesarean - Z38.69 Other multiple liveborn infant, delivered by cesarean
      • born outside hospital - Z38.7 Other multiple liveborn infant, born outside hospital
    • omphalitis - P38.9 Omphalitis without hemorrhage
      • with mild hemorrhage - P38.1 Omphalitis with mild hemorrhage
      • without hemorrhage - P38.9 Omphalitis without hemorrhage
    • post-term - P08.21 Post-term newborn
    • prolonged gestation (over 42 completed weeks) - P08.22 Prolonged gestation of newborn
    • quadruplet - Z38.8 Other multiple liveborn infant, unspecified as to place of birth
      • born in hospital - Z38.63 Quadruplet liveborn infant, delivered vaginally
        • by cesarean - Z38.64 Quadruplet liveborn infant, delivered by cesarean
      • born outside hospital - Z38.7 Other multiple liveborn infant, born outside hospital
    • quintuplet - Z38.8 Other multiple liveborn infant, unspecified as to place of birth
      • born in hospital - Z38.65 Quintuplet liveborn infant, delivered vaginally
        • by cesarean - Z38.66 Quintuplet liveborn infant, delivered by cesarean
      • born outside hospital - Z38.7 Other multiple liveborn infant, born outside hospital
    • seizure - P90 Convulsions of newborn
    • sepsis (congenital) - P36.9 Bacterial sepsis of newborn, unspecified
      • due to
        • anaerobes NEC - P36.5 Sepsis of newborn due to anaerobes
        • Escherichia coli - P36.4 Sepsis of newborn due to Escherichia coli
        • Staphylococcus - P36.30 Sepsis of newborn due to unspecified staphylococci
          • aureus - P36.2 Sepsis of newborn due to Staphylococcus aureus
          • specified NEC - P36.39 Sepsis of newborn due to other staphylococci
        • Streptococcus - P36.10 Sepsis of newborn due to unspecified streptococci
          • group B - P36.0 Sepsis of newborn due to streptococcus, group B
          • specified NEC - P36.19 Sepsis of newborn due to other streptococci
      • specified NEC - P36.8 Other bacterial sepsis of newborn
    • triplet - Z38.8 Other multiple liveborn infant, unspecified as to place of birth
      • born in hospital - Z38.61 Triplet liveborn infant, delivered vaginally
        • by cesarean - Z38.62 Triplet liveborn infant, delivered by cesarean
      • born outside hospital - Z38.7 Other multiple liveborn infant, born outside hospital
    • twin - Z38.5 Twin liveborn infant, unspecified as to place of birth
      • born in hospital - Z38.30 Twin liveborn infant, delivered vaginally
        • by cesarean - Z38.31 Twin liveborn infant, delivered by cesarean
      • born outside hospital - Z38.4 Twin liveborn infant, born outside hospital
    • vomiting - P92.09 Other vomiting of newborn
      • bilious - P92.01 Bilious vomiting of newborn
    • weight check - Z00.111 Health examination for newborn 8 to 28 days old